İkbal KAYGUSUZ, İlknur İNEGÖL GÜMÜŞ, Özlem ONUR, HİLAL USLU YUVACI, Evren SARIFAKIOĞLU

Can pregabaline be an alternative treatment for vulvodynia?

Vulvodini genel populasyonun %16’ını etkileyen etyolojisi tam belli olmayan, kronik, heterojen bir hastalıktır. Doğru tanı için tam hikaye, fizik muayene ve bazı tanısal testler gerekmektedir. Birçok tedavi seçenekleri uygu lanmasına rağmen doğru terapötik tedavi stratejileri halen araştırılmaktadır. Biz bu yazımızda 60 yaşında, bir yıldır vulvodini hikayesi olan ve medikal tedavilere cevap vermemiş, ancak pregabalin ile başarılı sonuç aldığımız hastamızı vaka takdimi olarak sunduk ve vulvodini tedavisi için pregabalinin alternatif bir tedavi seçeneği olup olmayacağını tartıştık.

Anahtar Kelimeler:

Orta yaşlı, Kadın, Vulva hastalıkları, Vulvodini, Ağrı

Pregabalin vulvodini için alternatif bir tedavi olabilir mi?

Vulvodynia is a chronic, heterogeneous, and multifacto rial disease of uncertain etiology that affects up to 16% of women in the general population. An accurate diagnosis requires a comprehensive history, physical examination and targeted diagnostic tests. Although many treatment options have been utilized, a rational therapeutic strategy is still under research. We present a case of a 60-year-old woman presenting with a one-year history of vulvodynia previously unresponsive to medical treatment and successful medical management of this chronic pain disorder with pregabaline.

Keywords:

Middle Aged, Female, Vulvar Diseases, Vulvodynia, Pain,

PDF

___

1. Moyal-Barracco M, Lynch PJ. 2003 ISSVD Terminology and classification of vulvodynia. A historical perspective. J Reprod Med 2004; 49(10):772-7.
2. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003;189(3):24–30.
3. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58(2):82-8.
4. Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol 2008;112(2 Pt 1):231-7.
5. Reed BD. Vulvodynia: Diagnosis and management. Am Fam Physician 2006;73(7):1231-8.
6. Heim LJ. Evaluation and differential diagnosis of dyspareunia. Am Fam Physician 2001;63(8):1535-44.
7. Smart OC, MacLean AB. Vulvodynia. Curr Opin Gynecol 2003;15 (6):497-500
8. Sadownik LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med 2000;45(8):679–84.
9. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9(1):40–51.
10. Mariani L. Vulvar vestibulitis syndrome: a review of non-surgical treatment. Eur J Gynecol Reprod Biol 2002;101(2):109-12.
11. Bachmann GA, Rosen R, Arnold LD, Burd I, Rhoads GG, Leiblum SR, et al: Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. J Reprod Med 2006;51(1):3–9.
12. Bergeon S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91(3):297-306.
13. Tmpanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003;148(5):1021-7.
14. Gumus II, Sarifakioglu E, Uslu H, Oztuk NO. Vulvodynia: Case report and review of literature. Gynecol Obstet 158 Invest 2008;65(3): 155–61.
15. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52(4):1264-73.
16. L Jerome. Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain Res Manage 2007;12(3):212-4.